Evidence map›Paper›PMID 41368436›Full record

ArticleFrontiers in cellular and infection microbiology2025

Enterohemorrhagic

Jaromír Háček, Alena Vlková, Daniel Krsek, Lukáš Kolařík, Alžběta Spálenková, Tomáš Sychra, Tereza Tesařová, Emin Gayibov, Radka Václavíková, Jakub Zieg and 1 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Clinical features ofFrontiers in cellular and infection microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jaromír HáčekDepartment of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University, and University Hospital Motol, Prague, Czechia.
Alena VlkováDepartment for Welfare of Laboratory Animals, Centre for Toxicology and Health Safety, National Institute of Public Health, Prague, Czechia.
Daniel KrsekNational Reference Laboratory for Detection of Infectious Agents by Electron Microscopy, Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czechia.
Lukáš KolaříkDepartment of Clinical Hematology, University Hospital Motol, Prague, Czechia.
Alžběta SpálenkováDepartment of Toxicogenomics, Centre for Toxicology and Health Safety, National Institute of Public Health, Prague, Czechia.
Tomáš SychraDepartment of Toxicogenomics, Centre for Toxicology and Health Safety, National Institute of Public Health, Prague, Czechia.
Tereza TesařováDepartment of Toxicogenomics, Centre for Toxicology and Health Safety, National Institute of Public Health, Prague, Czechia.
Emin GayibovDepartment of General Surgery, Third Faculty of Medicine, Charles University, and University Hospital Královské Vinohrady, Prague, Czechia.
Radka VáclavíkováDepartment of Toxicogenomics, Centre for Toxicology and Health Safety, National Institute of Public Health, Prague, Czechia.
Jakub ZiegDepartment of Pediatrics, Second Faculty of Medicine, Charles University, and University Hospital Motol, Prague, Czechia.
Martina BielaszewskaNational Reference Laboratory for E. coli and Shigella, Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czechia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Outer membrane vesicles (OMVs) secreted by enterohemorrhagic Methods: The sera and kidneys of BALB/c mice orally administered EHEC O157 OMVs were examined for OMVs by immunoelectron and confocal immunofluorescence microscopy. Histopathological evaluation of the kidneys was performed by light and electron microscopy, and blood analyses were conducted using standard methods. The cytotoxicity of EHEC O157 OMVs toward human renal glomerular endothelial cells (HRGECs) and tubular epithelial cells (HK-2) was determined by Cell Death ELISA. In addition, sera from patients with EHEC O157-associated HUS were examined for O157 OMVs by immunoelectron microscopy. Results: EHEC O157 OMVs were detected in the sera and kidneys of mice orally administered 100-400 µg of OMVs. The mice exhibited renal tubular epithelial damage and had significantly increased serum creatinine and blood urea nitrogen levels, indicating acute kidney failure. EHEC O157 OMVs induced apoptosis in HRGECs and HK-2 cells, the primary targets in EHEC-HUS. Moreover, EHEC O157 OMVs were found in the sera of patients with EHEC O157-associated HUS. Conclusion: Orally administered EHEC O157 OMVs translocated from the gastrointestinal tract to the kidneys, where they caused tubular epithelial injury followed by acute kidney failure. Combined with their cytotoxicity toward HRGECs and HK-2 cells and detection in patient sera, these findings indicate that EHEC O157 OMVs contribute to the pathogenesis of EHEC-HUS.

Indexed as

Acute Kidney InjuryEscherichia coli InfectionsEscherichia coli O157Kidney TubulesAdministration, OralAnimalsDisease Models, AnimalHemolytic-Uremic SyndromeHumansMiceMice, Inbred BALB CShiga Toxin 2Shiga Toxin 2acute kidney failureenterohemorrhagic Escherichia coli (EHEC)hemolytic uremic syndromemouse modeloral gavageouter membrane vesiclesrenal tubular damageShiga toxin

Identifiers

PMID41368436
PMCPMC12682904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.